Stage II-III Gastric Cancer
3 clinical trials · Condition
◉ Watch Stage II-III Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer (NCT06609759) | Qilu Hospital of Shandong University | 2024-01-01 |
| Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer (NCT06157216) | Qilu Hospital of Shandong University | 2023-10-01 |
| A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC) (NCT03403296) | Yonsei University | 2016-07-13 |
Track Stage II-III Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.